UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1113-1125

2014

Volltextzugriff (PDF)

Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (6), p.557-576

2009

Volltextzugriff (PDF)

Review article: drug therapy for non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2006-01, Vol.23 (2), p.207-215

2006

Volltextzugriff (PDF)

PROMIS computerised adaptive tests are dynamic instruments to measure health‐related quality of life in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2011-11, Vol.34 (9), p.1123-1132

2011

Volltextzugriff (PDF)

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.319-331

2017

Volltextzugriff (PDF)

Modified-orientation log to assess hepatic encephalopathy

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (8), p.913-920

2012

Volltextzugriff (PDF)

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1164-1172

1999

Volltextzugriff (PDF)

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Volltextzugriff (PDF)

Right lobe living donor liver transplantation

Transplantation, 1999-09, Vol.68 (6), p.798-803

1999

Volltextzugriff (PDF)

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation

Transplantation, 2000-04, Vol.69 (7), p.1375

2000

Volltextzugriff (PDF)

Selection and outcome of living donors for adult to adult right lobe transplantation

Transplantation, 2000-06, Vol.69 (11), p.2410-2415

2000

Volltextzugriff (PDF)

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.638-643

2016

Volltextzugriff (PDF)

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT‐C trial

Alimentary pharmacology & therapeutics, 2009-03, Vol.29 (5), p.589-601

2009

Volltextzugriff (PDF)

A prospective, randomized‐controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2004-11, Vol.20 (9), p.943-949

2004

Volltextzugriff (PDF)

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study

Radiology, 2000-04, Vol.215 (1), p.71-80

2000

Volltextzugriff (PDF)

The spectrum of hepatic functional impairment in compensated chronic hepatitis C : results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial

Alimentary pharmacology & therapeutics, 2008-05, Vol.27 (9), p.798-809

2008

Volltextzugriff (PDF)

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1001-1011

2018

Volltextzugriff (PDF)

Portal‐systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt

Alimentary Pharmacology and Therapeutics, 2007-08, Vol.26 (3), p.401-410

2007

Volltextzugriff (PDF)

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (7), p.671-685

2015

Volltextzugriff (PDF)

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.1183-1192

2001

Volltextzugriff (PDF)

Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

The American journal of gastroenterology, 1999-12, Vol.94 (12), p.3576-3582

1999

Volltextzugriff (PDF)

The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high‐risk Hispanic population

HIV medicine, 2009-10, Vol.10 (9), p.555-563

2009

Volltextzugriff (PDF)

Liver transplantation. Living donor, hepatocyte, and xenotransplantation

Clinics in liver disease, 2001, Vol.5 (2), p.431-460

2001

Volltextzugriff (PDF)

The association of HIV viral load with indirect markers of liver injury

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.e202-e211

2012

Volltextzugriff (PDF)

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

Liver transplantation, 2001-04, Vol.7 (4), p.363-373

2001

Volltextzugriff (PDF)

1 – 25 von 1.074

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(998)
Mit Volltextzugriff
(847)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C

Review article: drug therapy for non‐alcoholic fatty liver disease

PROMIS computerised adaptive tests are dynamic instruments to measure health‐related quality of life in patients with cirrhosis

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Modified-orientation log to assess hepatic encephalopathy

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Right lobe living donor liver transplantation

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation

Selection and outcome of living donors for adult to adult right lobe transplantation

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT‐C trial

A prospective, randomized‐controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study

The spectrum of hepatic functional impairment in compensated chronic hepatitis C : results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Portal‐systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high‐risk Hispanic population

Liver transplantation. Living donor, hepatocyte, and xenotransplantation

The association of HIV viral load with indirect markers of liver injury

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

Suchergebnisse filtern